XBiotech Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
Others were interested in
See all stocksFrequently asked questions
To buy XBiotech Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for XBiotech Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for XBiotech Inc. is XBIT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
XBiotech Inc. has its primary listing on NASDAQ. You can trade XBiotech Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, XBiotech Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include XBiotech Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like XBiotech Inc..